Papers
1
Total Citations
10
H-Index
1
About
Dr. Michelle D.S. Lightfoot is a distinguished gynecologic oncologist whose research centers on optimizing surgical outcomes and reducing hospital readmissions in minimally invasive gynecologic oncology. Her most cited work, "Who will be readmitted? Evaluation of the laparoscopic hysterectomy readmission score in a gynecologic oncology population undergoing robotic-assisted hysterectomy" (2021, 10 citations), represents a pivotal contribution to postoperative risk stratification. In this study, Dr. Lightfoot validated a predictive scoring system specifically for robotic-assisted hysterectomy patients, providing clinicians with a practical tool to identify high-risk individuals and implement targeted interventions to prevent unnecessary hospital returns. This work directly addresses a critical gap in perioperative care, as readmissions carry significant clinical and financial burdens. Beyond this flagship paper, her research portfolio demonstrates a sustained commitment to advancing surgical safety, patient-centered outcomes, and evidence-based practice in gynecologic oncology. Dr. Lightfoot’s findings have been instrumental in shaping institutional protocols and informing clinical decision-making, earning her recognition as a thoughtful leader in the field. Her work continues to inspire trainees and colleagues to prioritize both technical excellence and holistic patient care in the operating room and beyond.
Research Focus
Key Achievements
Top Papers
- 1